Balyasny Asset Management
CADL icon

Balyasny Asset Management’s Candel Therapeutics CADL Stock Holding History

Balyasny Asset Management’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,710
Closed -$213K – 2043
2025
Q1 		$213K Buy
+37,710
New +$213K ﹤0.01% 1799